Block XYZ Q1 2026 Earnings EPS Crushes Estimates by 244 as Profitability Improves SBLK Q1 2026 Earnings Strong EPS Beat Amid Dry Bulk Headwinds SGMT Q1 2026 Earnings EPS Beat as Clinical Development Costs Tighten MSDL Q1 2026 Earnings Small EPS Beat Meets Modest Market Pullback Verastem Inc Q1 2026 Earnings Narrowerthanexpected loss amid ongoing clinical developments DHCNI Q1 2026 Earnings Net Loss Misses Estimates Amid Challenging Environment